RA Capital

Asia
Pharma

Astellas, Takeda, RA Capital—Fierce Pharma Asia

Astellas CEO lays out the firm's new five-year plan. Takeda beats BMS in a psoriasis trial. RA provides China capabilities to its portfolio. And more.
Angus Liu Jun 12, 2026 8:23am
Capitol building in Washington
Favicon Fierce Biotech

A divisive bill seeks to limit biotech investment in China

Jun 4, 2026 10:54am
spermatozoa sperm and egg conception contraception birth control family planning

Contraline gins up $92.5M in male birth control development push

Jun 2, 2026 8:00am
Ramaswamy
Favicon Fierce Biotech

Ramaswamy-backed Ambros launches with $125M to develop pain med

Dec 16, 2025 1:32pm
Illustration of two people shaking hands standing on money and a lightbulb

Sublingual psychedelic startup nets $60M for depression trials

Nov 8, 2022 7:30am
money private equity venture capital investment cash dollar sign investor

Getting Cerebral: VCs bet $40M on epilepsy implant development

Jul 5, 2022 8:55am